In a previous study analyzing 26 patients, there was a prevalence of SS-associated serum autoantibodies (48% anti-nuclear antibody (ANA), 32% rheumatoid factor (RF), 48% SS-A, and 25% SS-B) [92]. The gene discussed is BTG3; the disease is synovial sarcoma.